No, NanoString Technologies, as an independent operating entity, is no longer in business. Its business operations, assets, and associated rights were acquired by Bruker Corporation.
The Acquisition by Bruker Corporation
The transition of NanoString Technologies into part of Bruker Corporation was finalized in April 2024. On April 19, 2024, the sale of NanoString Technologies to Bruker Corporation received approval. Later that same month, Bruker announced a definitive agreement had been reached and entered between the companies.
As part of this significant transaction, Bruker acquired all the assets and rights associated with NanoString's business. This comprehensive acquisition was completed for $392.6 million in cash.
Impact on NanoString's Operations and Technology
While the NanoString Technologies company no longer exists as a standalone entity, its innovative technologies and product lines are now under the ownership and management of Bruker Corporation. This means that the advanced scientific tools and platforms developed by NanoString, particularly in areas like spatial biology and gene expression, are expected to continue to be available and supported.
The acquisition allows for the integration of NanoString's cutting-edge technologies into Bruker's broader portfolio of scientific instruments and solutions, potentially expanding their reach and further developing their capabilities under a new corporate structure.
Key Details of the Acquisition
To provide a clear overview of this corporate event, here are the essential details of the transaction:
| Detail | Description |
|---|---|
| Acquired Entity | NanoString Technologies |
| Acquiring Company | Bruker Corporation |
| Approval Date | April 19, 2024 |
| Acquisition Type | Acquisition of assets and business rights |
| Transaction Value | $392.6 million in cash |
In summary, NanoString Technologies transitioned from an independent company to being part of Bruker Corporation in April 2024, marking the end of its standalone business operations.
